The Heart Program at Nicklaus Children's Hospital, formerly Miami Children's Hospital, is an international leader in the development of interventional cardiac catheterization techniques to treat congenital heart disorders.
The pediatric interventional cardiology program was one of only three centers nationwide chosen to participate in a clinical trial to evaluate the safety and effectiveness of the Melody transcatheter pulmonary valve in patients with dysfunctional right ventricular outflow. The device, developed by Medtronic, Inc, makes possible the replacement of a patient’s pulmonary valve without open-heart surgery. As a result of the trial, the device received FDA approval in 2010.
Video-assisted endoscopic techniques for congenital heart disease were pioneered at The Heart Program. Using endoscopic cameras and specially designed instruments, several cardiac abnormalities can now be corrected through small punctures, avoiding large incisions in the patient’s chest. This minimally traumatic technique of interventional cardiology results in less post-operative pain, more rapid recovery and enhanced cosmetic results for the patient.
The following heart defects have been repaired using pediatric interventional cardiology:
The Heart Program at Nicklaus Children's will host a Medical Conference on technology and innovation in the treatment of pediatric heart disease.
The hospital’s use of 3D printing technology has proven to be instrumental in creating surgical solutions for children with complex congenital heart defects, who had been considered to be inoperable using conventional imaging techniques.
The Heart Program at Miami Children’s Hospital Uses 3D Printing Technology to Plan Complex Heart Surgery on Pediatric Patient